The global Urolithin market size is predicted to grow from US$ 266 million in 2025 to US$ 438 million in 2031; it is expected to grow at a CAGR of 8.6% from 2025 to 2031.

Urolithins are a class of compounds produced by intestinal microorganisms after metabolizing certain plant components (such as tannic acid and certain polyphenols). They are believed to have a variety of biological activities, including antioxidant, anti-inflammatory and potential anti-cancer properties. Urolithin is divided into two types: Urolithin A and Urolithin B. Urolithin A is a natural product that can be obtained by hydrolyzing tannic acid in plants such as strawberries and pomegranates. In recent years, studies have found that urolithin A has multiple functions, including promoting muscle cell growth and metabolism, reducing oxidative stress, and relieving inflammation, and has been shown to be beneficial for improving human health, especially for the health of the elderly and delaying aging and related muscle degeneration and neurodegenerative diseases. At present, this beneficial natural product is under further research and development. Through refined manufacturing and product positioning, the preparation of urolithin A can help consumers provide better health protection.

United States market for Urolithin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Urolithin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Urolithin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Urolithin players cover Daicel Corporation, Sabinsa, Bonerge Lifescience, Verdant Nature, Sinoway Industrial Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the Urolithin Industry Forecast looks at past sales and reviews total world Urolithin sales in 2024, providing a comprehensive analysis by region and market sector of projected Urolithin sales for 2025 through 2031. With Urolithin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Urolithin industry.

This Insight Report provides a comprehensive analysis of the global Urolithin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Urolithin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Urolithin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Urolithin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Urolithin.

This report presents a comprehensive overview, market shares, and growth opportunities of Urolithin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Urolithin A (UA)
    Urolithin B

Segmentation by Application:

    Food
    Pharmaceuticals
    Health Products
    Personal Care

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Daicel Corporation
    Sabinsa
    Bonerge Lifescience
    Verdant Nature
    Sinoway Industrial Co., Ltd.
    Hygieia Biotech
    Wuxi Cima Science Co., Ltd
    Focusherb Corp
    BOC Sciences
    Tru Herb
    Herb Green Health Biotech
    Kerry (Natreon)
    Eleonor
    Shandong Chenghui Shuangda Pharmaceutical Co. Ltd.
    FENGCHEN GROUP CO., LTD.
    Shaanxi TNJONE Pharmaceutical Technology Co., Ltd.
    WUHAN DKY TECHNOLOGY CO.,LTD
    Suzhou MyLand Pharm & Nutrition Inc.
    AHUALYN Corp
    Wuxi Further Pharmaceutical Co.. Ltd.
    Xian Lyna Bio-Tech Co.,Ltd
    Green Strong International CO.,LTD

Key Questions Addressed in this Report

What is the 10-year outlook for the global Urolithin market?
What factors are driving Urolithin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Urolithin market opportunities vary by end market size?
How does Urolithin break out by Type, by Application?